Cerebral Infarctions Completed Phase 4 Trials for Acetylsalicylic acid (DB00945)

Also known as: Cerebral Infarct / Cerebral Infarction / Stroke NOS / Infarct cerebral

IndicationStatusPhase
DBCOND0047013 (Cerebral Infarctions)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00004727Antiplatelet Therapy to Prevent Stroke in African AmericansPrevention
NCT00234065Post-marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2)Prevention
NCT00272454Cilostazol in Acute Ischemic Stroke Treatment (CAIST)Treatment
NCT00741286Effect of Cilostazol in the Acute Lacunar Infarction Based on Pulsatility Index of Transcranial DopplerTreatment
NCT00766896Platelet Hyperreactivity to Aspirin and StrokeDiagnostic